Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 18-Jul-17 2:14 PM View:  | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Jul-17 | Option Exercise | 2,663 | -- | -- | 27% 9.7K to 12.36K | |
| 18-Jul-17 2:14 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Jul-17 | Option Sale | 1,250 | $6.50 | $8,125.00 | (10%) 12.36K to 11.11K | |
| 05-Jul-17 6:22 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 05-Jul-17 | Sale | 1,175 | $6.75 | $7,931.25 | (2%) 70.13K to 68.96K | |
| 05-Jul-17 6:25 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 05-Jul-17 | Option Sale | 3,700 | $6.75 | $24,975.00 | (8%) 47.83K to 44.13K | |
| 05-Jul-17 6:25 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Jul-17 | Option Exercise | 7,473 | -- | -- | 19% 40.35K to 47.83K | |
| 20-Jun-17 4:20 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 20-Jun-17 | Option Sale | 1,300 | $6.95 | $9,035.00 | (12%) 10.99K to 9.7K | |
| 20-Jun-17 4:20 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Jun-17 | Option Exercise | 2,664 | -- | -- | 32% 8.33K to 10.99K | |
| 02-Jun-17 2:19 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Jun-17 | Option Sale | 3,380 | $7.38 | $24,944.40 | (8%) 43.73K to 40.35K | |
| 02-Jun-17 2:16 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Jun-17 | Sale | 1,080 | $7.38 | $7,970.40 | (2%) 71.21K to 70.13K | |
| 02-Jun-17 2:19 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Jun-17 | Option Exercise | 7,473 | -- | -- | 21% 36.26K to 43.73K | |
| 18-May-17 2:57 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-May-17 | Option Exercise | 2,663 | -- | -- | 38% 6.94K to 9.61K | |
| 18-May-17 2:57 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-May-17 | Option Sale | 1,275 | $6.15 | $7,841.25 | (13%) 9.61K to 8.33K | |
| 02-May-17 1:51 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-May-17 | Option Sale | 3,615 | $6.15 | $22,232.20 | (9%) 39.88K to 36.26K | |
| 02-May-17 2:02 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-May-17 | Sale | 1,100 | $6.15 | $6,765.00 | (2%) 72.31K to 71.21K | |
| 02-May-17 1:51 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-May-17 | Option Exercise | 7,473 | -- | -- | 23% 32.4K to 39.88K | |
| 17-Apr-17 4:50 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Apr-17 | Option Exercise | 2,664 | -- | -- | 48% 5.6K to 8.26K | |
| 17-Apr-17 4:50 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Apr-17 | Option Sale | 1,320 | $6.48 | $8,553.60 | (16%) 8.26K to 6.94K | |
| 04-Apr-17 8:32 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 04-Apr-17 | Sale | 1,100 | $6.75 | $7,425.00 | (1%) 73.41K to 72.31K | |
| 04-Apr-17 8:39 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 04-Apr-17 | Option Sale | 3,400 | $6.75 | $22,950.00 | (9%) 35.8K to 32.4K | |
| 04-Apr-17 8:39 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Apr-17 | Option Exercise | 7,472 | -- | -- | 26% 28.33K to 35.8K | |
| 20-Mar-17 6:46 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 20-Mar-17 | Option Sale | 1,250 | $7.10 | $8,875.00 | (18%) 6.85K to 5.6K | |
| 20-Mar-17 6:46 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Mar-17 | Option Exercise | 2,663 | -- | -- | 64% 4.19K to 6.85K | |
| 02-Mar-17 4:34 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 02-Mar-17 | Option Sale | 3,550 | $7.70 | $27,335.00 | (11%) 31.88K to 28.33K | |
| 02-Mar-17 4:38 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 02-Mar-17 | Sale | 1,250 | $7.72 | $9,650.00 | (2%) 74.66K to 73.41K | |
| 02-Mar-17 4:34 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Mar-17 | Option Exercise | 7,473 | -- | -- | 31% 24.41K to 31.88K | |
| 08-Mar-17 1:46 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 28-Feb-17 | Disposition (other) | 6,196,870 | $49,711,600.00 | $308,055,992,434,688.00 | (30%) 20.68M to 14.49M | |
| 08-Mar-17 1:46 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 28-Feb-17 | Acquisition (other) | 6,196,870 | $49,711,600.00 | $308,055,992,434,688.00 | 43% 14.49M to 20.68M | |
| 21-Feb-17 7:11 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Feb-17 | Option Exercise | 2,664 | -- | -- | 90% 2.97K to 5.64K | |
| 21-Feb-17 7:11 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Feb-17 | Option Sale | 1,450 | $8.10 | $11,745.00 | (26%) 5.64K to 4.19K | |
| 03-Feb-17 3:47 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 02-Feb-17 | Option Sale | 3,875 | $8.60 | $33,325.00 | (14%) 28.28K to 24.41K | |
| 03-Feb-17 3:47 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 02-Feb-17 | Sale | 1,250 | $8.50 | $10,625.00 | (2%) 75.91K to 74.66K | |
| 03-Feb-17 3:47 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Feb-17 | Option Exercise | 7,473 | -- | -- | 36% 20.81K to 28.28K | |
| 08-Feb-17 2:25 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 23-Jan-17 | Purchase | 17,200 | $150,643.00 | $2,591,059,968.00 | < 1% 14.47M to 14.49M | |
| 08-Feb-17 2:25 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 20-Jan-17 | Purchase | 12,900 | $111,884.00 | $1,443,309,952.00 | < 1% 14.46M to 14.47M | |
| 08-Feb-17 2:25 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 19-Jan-17 | Purchase | 100 | $869.60 | $86,960.00 | < 1% 14.46M to 14.46M | |
| 20-Jan-17 12:48 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 18-Jan-17 | Option Sale | 1,475 | $8.70 | $12,832.50 | (33%) 4.45K to 2.97K | |
| 20-Jan-17 12:48 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 17-Jan-17 | Option Exercise | 2,663 | -- | -- | 149% 1.78K to 4.45K | |
| 08-Feb-17 2:25 PM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 12-Jan-17 | Purchase | 7,100 | $63,447.30 | $450,476,000.00 | < 1% 14.45M to 14.46M | |
| 06-Jan-17 3:36 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 04-Jan-17 | Sale | 1,270 | $8.58 | $10,896.60 | (2%) 77.18K to 75.91K | |
| 06-Jan-17 3:36 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 04-Jan-17 | Option Sale | 3,790 | $8.58 | $32,518.20 | (15%) 24.6K to 20.81K | |
| 06-Jan-17 3:36 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 01-Jan-17 | Option Exercise | 7,473 | -- | -- | 44% 17.13K to 24.6K | |
| 10-Jan-17 11:39 AM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 30-Dec-16 | Purchase | 2,700 | $22,970.10 | $62,019,100.00 | < 1% 14.45M to 14.45M | |
| 10-Jan-17 11:39 AM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 29-Dec-16 | Purchase | 16,900 | $143,507.00 | $2,425,270,016.00 | < 1% 14.43M to 14.45M | |
| 10-Jan-17 11:39 AM View: | Sbi Holdings, Inc. 10% Owner | Kubota Pharmaceutical Holdi... (NONE) | 28-Dec-16 | Purchase | 204,800 | $1,735,240.00 | $355,376,988,160.00 | 1% 14.22M to 14.43M | |
| 27-Dec-16 8:32 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 22-Dec-16 | Option Sale | 3,210 | $8.18 | $26,257.80 | (16%) 20.34K to 17.13K | |
| 27-Dec-16 8:30 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 22-Dec-16 | Option Exercise | 2,664 | -- | -- | 100% 0 to 2.66K | |
| 27-Dec-16 8:30 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 22-Dec-16 | Option Sale | 880 | $8.18 | $7,198.40 | (33%) 2.66K to 1.78K | |
| 27-Dec-16 8:32 PM View: | Gebhart John E Chief Financial Officer | Kubota Pharmaceutical Holdi... (NONE) | 22-Dec-16 | Option Exercise | 7,472 | -- | -- | 58% 12.87K to 20.34K | |
| 19-Dec-16 5:19 PM View: | Danse Edward H Chief Business Officer | Kubota Pharmaceutical Holdi... (NONE) | 15-Dec-16 | Sale | 1,090 | $8.75 | $9,537.50 | (1%) 78.27K to 77.18K | |
| 21-Nov-16 2:16 PM View: | Scheibler Lukas EVP of Research & Development | Kubota Pharmaceutical Holdi... (NONE) | 21-Nov-16 | Option Sale | 2,663 | $9.35 | $24,890.50 | (100%) 2.66K to 0 |
